Prescribing adequate antibiotics is one of the greatest challenges in current medicine due to the rapid emergence of antimicrobial-resistant superbugs. While treating infections with last-generation antibiotics increases the chances of eradicating superbugs, overusing these drugs accelerates the onset of new antimicrobial-resistant strains.

Rapid tests can help reduce this problem by quickly identifying if a superbug is causing an infection. By providing accurate information about the nature of the infection, healthcare providers can make informed decisions about the most suitable treatment, avoiding the unnecessary prescription of last-generation antibiotics. This targeted approach not only helps in preserving the effectiveness of existing antibiotics but also reduces the risk of adverse side effects for patients.

To address the growing concern of antimicrobial resistance, the first medical device in Nanodecal's pipeline provides rapid detection of Pseudomonas aeruginosa from sputum samples.

A Growing Concern

Antimicrobial resistant Pseudomonas is a growing concern in the medical community, as it poses a significant threat to public health. Pseudomonas aeruginosa is a common bacterium that can cause a wide range of infections, particularly in individuals with respiratory conditions such as COPD and Cystic Fibrosis. The increasing prevalence of antimicrobial resistance in this bacterium has made it more challenging to treat these infections effectively, leading to increased morbidity and mortality rates.

To address the growing concern of antimicrobial resistance, the first medical device in Nanodecal's pipeline provides rapid detection of Pseudomonas aeruginosa from sputum samples. This can provide doctors with real-world evidence that can guide the choice of treatment.

The Nanodecal Solution

Rapidly identifying Pseudomonas in sputum is an unmet medical need for many people living with respiratory conditions. This is because Pseudomonas infections must be treated quickly with specialized antibiotics, before the bacteria has an opportunity to grow biofilms in the lungs. If not treated quickly with the correct antibiotic, this bacteria can colonize the lungs leading to a chronic infection. Nanodecal aims to fill this unmet medical need by rapidly identifying Pseudomonas in a patient's sputum. Having this key piece of information at the right time is essential for providing personalized respiratory therapy that leads to better patient outcomes.